Article Details
Retrieved on: 2022-08-12 11:30:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The US FDA has granted approval for Daiichi Sankyo and AstraZeneca's Enhertu to treat unresectable or metastatic non-small cell lung cancer.
Article found on: www.pharmaceutical-technology.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here